血管内治疗后无症状性出血转化与卒中结局:一项基于人群的研究
基于加泰罗尼亚前瞻性卒中登记,纳入2017-2023年10家综合卒中中心接受EVT的前循环AIS患者3067例,其中无症状性HT 612例(20.0%)。校正混杂因素后,无症状性HT与3个月mRS更差(cOR 2.24,95%CI 1.89-2.66)及更高死亡率(aOR 1.50,95%CI 1.17-1.91)相关。
要点
- 接受EVT的前循环AIS患者中,无症状性HT发生率为20.0%。
- 无症状性HT与3个月功能结局更差独立相关(cOR 2.24)。
- 无症状性HT与死亡率升高独立相关(aOR 1.50)。
核心结论
- 在AIS接受EVT的患者中,无症状性HT与更差的功能结局和更高的死亡率相关,提示任何HT无论临床影响或影像学类型均应视为EVT安全性的额外指标。
研究设计与样本
- 基于加泰罗尼亚(西班牙)人群前瞻性卒中登记,纳入2017-2023年10家综合卒中中心的前循环AIS接受EVT患者,排除无HT数据或3个月功能结局缺失者,最终纳入3067例(72.0±13.6岁,50.7%女性)。
主要发现
- 共179例(5.8%)发生sICH,612例(20.0%)发生无症状性HT;HT类型频率为HI1 8.9%、HI2 7.2%、PH1 4.4%、PH2 3.8%、rPH 1.5%。
- 无症状患者比例呈等级分布,从HI1的93.4%至PH2的25.0%。
- 多变量分析中,无症状性HT与更差结局相关(cOR 2.24,95%CI 1.89-2.66),与更高死亡率相关(aOR 1.50,95%CI 1.17-1.91)。
- 敏感性分析中,各HT类型与功能结局的关联均显著,无症状性PH2的结局更差比值最高(cOR 3.15,95%CI 1.46-6.83)。
临床怎么用
- 在EVT术后评估中,无症状性HT也应被视为与不良结局相关的影像学发现,而不仅关注症状性出血。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: In patients with acute ischemic stroke (AIS), the impact of hemorrhagic transformation (HT) after endovascular treatment (EVT) on poorer stroke outcome is well established when associated with clinical deterioration. However, the influence of asymptomatic HT remains unclear. We aimed to examine the impact of asymptomatic HT after EVT on functional outcome and mortality. METHODS: Drawing on Catalan (Spain) population-based prospective stroke registry data, we included patients from 10 comprehensive stroke centers with anterior circulation AIS (2017-2023) who underwent EVT, excluding patients without data on the presence of HT or functional outcome at 3 months of follow-up. HT was categorized as parenchymal hemorrhage (PH), hemorrhagic infarct (HI) types 1 and 2, and remote PH (rPH). Asymptomatic HT was defined as any HT not causing death or the NIH Stroke Scale (NIHSS) score to increase by ≥ 4 points. Functional outcome was centrally assessed using the modified Rankin Scale (mRS). The primary end point was a shift in the 3-month mRS score. After excluding symptomatic intracerebral hemorrhage (sICH), multivariable ordinal regression analyses (adjusted by age, mRS, baseline NIHSS score, baseline Alberta Stroke Program Early CT Score, and modified Thrombolysis In Cerebral Infarction score ≥2b) were performed to test for asymptomatic HT association with the primary end point. RESULTS: We included 3,067 patients (72.0 ± 13.6 years, 50.7% women), 179 (5.8%) with sICH and 612 (20.0%) with asymptomatic HT. HT category frequencies were 8.9% HI1, 7.2% HI2, 4.4% PH1, 3.8% PH2, and 1.5% rPH. The percentage of asymptomatic patients showed a hierarchical distribution, ranging from 93.4% in HI1 to 25.0% in PH2. In the multivariable analysis, asymptomatic HT was associated with poorer outcomes (common odds ratio [cOR] 2.24, 95% CI 1.89-2.66) and higher mortality (adjusted odds ratio 1.50, 95% CI 1.17-1.91). In the sensitivity analyses, the association with functional outcome remained significant for each HT category, with asymptomatic PH2 showing the highest odds of poorer outcomes (cOR 3.15, 95% CI 1.46-6.83). DISCUSSION: In patients with AIS undergoing EVT, asymptomatic HT was associated with poorer functional outcomes and higher mortality, suggesting that any HT, regardless of its clinical impact or radiologic category, should be considered as an additional EVT safety measure.
引用
- Guasch-Jiménez M, Ezcurra Díaz G, Lambea-Gil Á, et al. Influence of Asymptomatic Hemorrhagic Transformation After Endovascular Treatment on Stroke Outcome: A Population-Based Study. Neurology. 2025. PMID: 40228188. doi:10.1212/WNL.0000000000213509
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。